Wealth Enhancement Advisory Services LLC Buys 4,359 Shares of Align Technology, Inc. $ALGN

Wealth Enhancement Advisory Services LLC grew its position in Align Technology, Inc. (NASDAQ:ALGN) by 38.9% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 15,551 shares of the medical equipment provider’s stock after purchasing an additional 4,359 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Align Technology were worth $2,029,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Rothschild Investment LLC grew its holdings in Align Technology by 140.3% during the 2nd quarter. Rothschild Investment LLC now owns 149 shares of the medical equipment provider’s stock worth $28,000 after acquiring an additional 87 shares during the period. True Wealth Design LLC boosted its position in shares of Align Technology by 7,650.0% in the 2nd quarter. True Wealth Design LLC now owns 155 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 153 shares during the last quarter. Cromwell Holdings LLC grew its stake in shares of Align Technology by 2,900.0% during the second quarter. Cromwell Holdings LLC now owns 180 shares of the medical equipment provider’s stock worth $34,000 after purchasing an additional 174 shares during the period. CYBER HORNET ETFs LLC acquired a new stake in shares of Align Technology during the second quarter worth $36,000. Finally, MUFG Securities EMEA plc bought a new stake in Align Technology in the second quarter valued at about $38,000. Institutional investors own 88.43% of the company’s stock.

Align Technology Stock Performance

Shares of ALGN stock opened at $163.03 on Friday. Align Technology, Inc. has a 52-week low of $122.00 and a 52-week high of $232.20. The stock has a market cap of $11.70 billion, a price-to-earnings ratio of 31.60, a PEG ratio of 1.84 and a beta of 1.83. The firm’s 50-day moving average is $161.01 and its 200-day moving average is $149.53.

Align Technology (NASDAQ:ALGN) last released its quarterly earnings data on Wednesday, October 29th. The medical equipment provider reported $2.61 EPS for the quarter, topping analysts’ consensus estimates of $2.38 by $0.23. The firm had revenue of $995.69 million during the quarter, compared to analysts’ expectations of $980.75 million. Align Technology had a net margin of 9.50% and a return on equity of 13.96%. The company’s revenue for the quarter was up 1.8% compared to the same quarter last year. During the same period in the previous year, the business posted $2.35 earnings per share. Sell-side analysts predict that Align Technology, Inc. will post 7.98 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on ALGN. Jefferies Financial Group boosted their target price on Align Technology from $140.00 to $155.00 in a research report on Thursday, October 30th. Morgan Stanley boosted their price objective on shares of Align Technology from $142.00 to $154.00 and gave the company an “equal weight” rating in a report on Thursday, October 30th. Weiss Ratings upgraded shares of Align Technology from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, January 16th. Barclays started coverage on shares of Align Technology in a report on Monday, December 8th. They issued an “equal weight” rating and a $170.00 price target for the company. Finally, Evercore ISI dropped their price objective on Align Technology from $220.00 to $170.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 25th. Six research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $176.82.

About Align Technology

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.